Identification and characterization of fully human anti-CD22 monoclonal antibodies.
about
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.Lessons learned from a highly-active CD22-specific chimeric antigen receptor.From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domain.CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies.Chimeric antigen receptors that trigger phagocytosis.
P2860
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@ast
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@en
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@nl
type
label
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@ast
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@en
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@nl
prefLabel
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@ast
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@en
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@nl
P2093
P2860
P356
P1476
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
@en
P2093
Dimiter S Dimitrov
Ira Pastan
Mitchell Ho
Xiaodong Xiao
Zhongyu Zhu
P2860
P304
P356
10.4161/MABS.1.3.8113
P577
2009-05-05T00:00:00Z